Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
2.85   0.00 (0.00%)  0.00 - 0.00  0
Analyze this stock with MQ Trader system

Financials


Market Cap: 2,013 Million

Market Cap 2,013 Million
NOSH 706 Million

Latest Audited Result:  31-Dec-2020

Latest Audited Result: 31-Dec-2020
Announcement Date 28-Apr-2021
Next Audited Result: 31-Dec-2021
Est. Ann. Date: 28-Apr-2022
Est. Ann. Due Date: 29-Jun-2022

Latest Quarter:  31-Mar-2021 [#1]

Latest Quarter: 31-Mar-2021 [#1]
Announcement Date 03-May-2021
Next Quarter: 30-Jun-2021
Est. Ann. Date: 13-Aug-2021
Est. Ann. Due Date: 29-Aug-2021
QoQ | YoY   8.78%  |    29.89%

Annual (Unaudited) ( EPS: 8.30, P/E: 34.35 )

Revenue | NP to SH 569,902  |  58,610
RPS | P/RPS 80.68 Cent  |  3.53
EPS | P/E | EY 8.30 Cent  |  34.35  |  2.91%
DPS | DY | Payout % 6.50 Cent  |  2.28%  |  78.30%
NAPS | P/NAPS 0.91  |  3.13
YoY   6.04%
NP Margin | ROE 10.28%  |  9.12%
F.Y. | Ann. Date 31-Dec-2020  |  22-Feb-2021

T4Q Result ( EPS: 8.87, P/E: 32.12 )

Revenue | NP to SH 577,643  |  62,663
RPS | P/RPS 81.78 Cent  |  3.48
EPS | P/E | EY 8.87 Cent  |  32.12  |  3.11%
DPS | DY | Payout % 6.48 Cent  |  2.27%  |  73.06%
NAPS | P/NAPS 0.90  |  3.17
QoQ | YoY   6.92%  |    15.26%
NP Margin | ROE 10.85%  |  9.86%
F.Y. | Ann. Date 31-Mar-2021  |  03-May-2021

Annualized Result ( EPS: 9.97, P/E: 28.57 )

Revenue | NP to SH 665,816  |  70,456
RPS | P/RPS 94.26 Cent  |  3.02
EPS | P/E | EY 9.97 Cent  |  28.57  |  3.50%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   20.21%  |    29.89%
NP Margin | ROE 10.58%  |  11.09%
F.Y. | Ann. Date 31-Mar-2021  |  03-May-2021



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 2 / 4 50.00% 2 / 8 25.00%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 2 / 4 50.00% 2 / 8 25.00%
Continuous Quarters Of Adjusted EPS Growth 2 / 4 50.00% 2 / 8 25.00%
Total Dividend Years 2 / 4 50.00% 4 / 8 50.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 2.56% 2.59%
Average Net Profit Margin 10.88% 10.09%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 0 / 5 0.00% 0 / 10 0.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Profit Growth 4 / 5 80.00% 4 / 10 40.00%
Continuous Years Of Adjusted EPS Growth 4 / 5 80.00% 4 / 10 40.00%
Total Dividend Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend Growth 5 / 5 100.00% 5 / 10 50.00%
Continuous Years Of Adjusted Dps Growth 5 / 5 100.00% 5 / 10 50.00%
Average ROE 8.86% 12.64%
Average Net Profit Margin 9.40% 15.01%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 577,643 665,816 569,902 330,950 485,202
NP to SH 62,663 70,456 58,610 39,017 46,226
Dividend 45,783 - 45,891 27,531 33,015
Adjusted EPS 8.87 9.97 8.30 5.54 6.58
Adjusted DPS 6.48 0.00 6.50 3.90 4.68

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 24.14% 4.88% 4.88% 15.26% 14.56%
NP to Owner 8.78% 29.89% 29.89% 12.44% 20.40%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adj. EPS 8.73% 29.64% 29.64% 12.33% 20.23%
Adj. DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 1.36% 19.05% 74.54% 16.83% 37.22% 101.18% -1.14% 17.46% 72.20%
NP to Owner 6.92% 35.56% 60.60% 20.21% 52.42% 80.58% 6.04% 26.79% 50.22%
Dividend -0.24% 38.67% 66.30% - % - % - % 12.10% 39.00% 66.69%
Adj. EPS 4.96% 34.97% 60.23% 17.73% 51.39% 79.71% 8.06% 28.59% 52.65%
Adj. DPS -0.31% 38.57% 66.18% - % - % - % 12.10% 39.00% 66.69%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Trade this stock with T+7 trading account. Find out more.
  12 people like this.
 
Trevor777 You're not too keen or passionate about your Darling, aren't you? Above RM2 and you stood her up.
16/07/2021 9:34 PM
JuYeoh Sinopharm -
WHO's data reported for the efficacy against hospitalization is 79%
16/07/2021 11:14 PM
rr1688 SOUTH KOREA trusts SINOPHARM ...travelers vaccinated with SINOPHARM quarantine free...
17/07/2021 12:14 AM
MadCow75 seen like most of here also suprise when dpharma link with sinopharm... roti canai world... i just come to check check only... now confirm no one here know b4 today...
17/07/2021 12:57 AM
128Huat https://klse.i3investor.com/blogs/128Huat/2021-07-16-story-h1568014312-DUOPHARMA_BIOTECH_BHD_DPHARMA_7148_UNEXPECTED_JACKPOT.jsp
17/07/2021 1:29 AM
Trevor777 Just what do you expect him to say????..The whole world is eyeing all comments on Vaccines from every Govt.

If the efficacy is as perfect and up to expectations, WHY not continue since the system and machinery is purring like a Lamborghini???

Do you not know that the most diplomatic way to say things is to say it backwards???? He's well oiled.

https://www.theedgemarkets.com/article/sinovac-no-issue-vaccine-efficacy-says-khairy
17/07/2021 7:37 AM
Trevor777 Is it necessary to waste time and money to test Booster to expel fears of low efficacy (65%) of Sinovac??? To what results and purpose???

JUST GIVE A RELIABLE AND TRUSTED VACCINE, ONCE AND FOR ALL..case closed.

"More recently, a Hong Kong study indicated that those who received the Pfizer-BioNTech vaccine had 10 times the amount of antibodies than those given the Sinovac vaccine."

"Chile and Seychelles, which used China-made vaccines, had reported an increase in the number of Covid-19 cases despite having a very high vaccination rate of between 65% and 70% of their populations."

“Analysis has shown that Sinovac only has a 65% efficacy against symptomatic infection in contrast to a 96% and 92% efficacy of the Pfizer and AstraZeneca vaccines respectively.”


THIS SAYS IT ALL....: just take a DIFFERENT VACCINE, ONCE AND FOR ALL

"He said this was why countries that have used the Sinovac vaccine are reviewing their strategy, including proposing the mixing of vaccines and booster doses to overcome any shortcomings of the Sinovac vaccine."

https://www.msn.com/en-my/news/national/consider-a-third-jab-for-sinovac-recipients-govt-told/ar-AAMezpY?li=BBr8Hnu
17/07/2021 7:38 AM
Trevor777 And before anyone gets any bright ideas, the 3rd or Booster shot is ACTUALLY a mix Vaccine.....meaning to use ANOTHER RELIABLE vaccine to overcome any shortcomings from Sinovac.

SAY AGAIN,....3rd BOOSTER SHOT, if necessary...1000% DEFINITELY, certainly NOT Sinovac. End of case, no further discussions.
17/07/2021 8:00 AM
Trevor777 What else do you expect MOSTI to do? Faced with rising cases exceeding 13,000 and deaths of 80-120 each day? Even on increased vaccinations of 300-400K now, cases are as rampant as wild bush fires.

What seems to be the light at the end of a tunnel with more inoculations, turns out to be wet firecrackers, headlights from an on rushing truck.

There's no other choice but to switch vaccine, for the greater good of Rakyat. Although, he has graciously offer consolation on a Plan B and to deny low efficacy.

Consider it most unfortunate for Pharma to have keys to the front door, but not the keys to the Vault. Maybe better luck next time.

Money is secondary, when compared with lost lives...One last question, straight to the point...HAVE YOU EVER LOST A CLOSE FRIEND, RELATIVE, LOVED ONES TO COVID?
17/07/2021 9:23 AM
MZM2511 Report 2: Kanger International executive director Steven Kuah told reporters that, “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”

(Source: https://www.freemalaysiatoday.com/category/nation/2021/05/27/sabah-signs-mou-with-private-firm-to-obtain-sinopharm-vaccine/ )

Report 6: The states are free to negotiate with drug makers Moderna and Sinopharm, whose vaccines have been approved by the World Health Organization . Khairy said that as long as the vaccines have been given the green light by the National Pharmaceutical Regulatory Agency, the states are free to procure them.

(Source: https://www.freemalaysiatoday.com/category/nation/2021/06/03/state-govts-free-to-purchase-moderna-sinopharm-vaccines/ )
17/07/2021 2:43 PM
MZM2511 Khairy also mentioned that Covid-19 vaccines will enter the private market by August. He said that private vaccination will help the government ramp up the national Covid-19 vaccination programme, as those who are able to pay for the vaccines will be able to do so.

“I also anticipate by about August, we will have a private vaccine market. So right now, it’s difficult for private because vaccines are in short supply. But by August, I think that there will be SOME COMPANIES who WILL BE APPROVED to bring in SOME PRIVATE VACCINES from China. I know Sinopharm and all that are going to be registered here,” Khairy added.

“That’s also part of the plan. I’ve been talking to the Ministry of Health to ensure that the private market by August can take off to help us.”

Source: https://codeblue.galencentre.org/2021/06/24/khairy-projects-40-population-fully-vaccinated-by-end-august/
17/07/2021 2:48 PM
MZM2511 On the Sputnik Covid-19 vaccine produced by Russia, Khairy said that Duopharma Biotech Bhd’s wholly-owned subsidiary, Duopharma (M) Sdn Bhd (DMSB), which holds the distribution rights to the product, has three months to register the vaccine with the National Pharmaceutical Regulatory Agency (NPRA), after inking an agreement with the government earlier this month.

He said that the NPRA still requires further information on the vaccine.

“However, NPRA also said that it would simplify the registration process if Sputnik gets emergency use (status) from the World Health Organisation (WHO). Sputnik has not received the EUL from WHO yet,” he said, referring to the Emergency Use Listing.

Source: https://www.malaymail.com/news/malaysia/2021/06/21/khairy-cansino-vaccine-to-arrive-in-malaysia-next-month-no-updates-yet-on-j/1983852
17/07/2021 2:56 PM
gohkimhock Nigeria has become the 68th country in the world to approve the Sputnik V. Total population of all countries where Sputnik V is approved for use now exceeds 3.7 billion people, which is nearly half of the global population.
17/07/2021 3:21 PM
rr1688 CHINESE BUSINESSMEN,STUDENTS etc very LOYAL to SINOPHARM ...when SINOPHARM open to private n goverment sectors...telephones ring non stop in private clinics...the sound of KA CHING...KA CHING...KA CHING...IT IS HAPPENNING IN SINGAPORE...
17/07/2021 3:46 PM
rr1688 TRAVELERS vaccinated with SINOPHARM less document required when visiting CHINA...i love to visit CHINA...
17/07/2021 4:02 PM
Bgt 9963 Good morning.!
18/07/2021 11:15 AM
Vaccineyes Good afternoon even
18/07/2021 1:28 PM
128Huat Let's go, DPHARMA!!
19/07/2021 8:41 AM
Bgt 9963 Good morning.!
19/07/2021 8:54 AM
HonLee Haha...Expected heading south...Any expert want to comment
19/07/2021 9:46 AM
mo1malaysia Actually what happen ah? People keep dumping leh... Really holland lo..
19/07/2021 11:45 AM
MZM2511 The Board of Directors of Kanger (“Company”) wishes to announce that Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company had, on 19 July 2021 entered into Head of Agreement with Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.

Please refer to the full announcement as attached.

This announcement is dated 19 July 2021.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3176295

4.1 Quantity and specification of the Products

Quantity: Five Million (5,000,000) doses with an option to buy an additional Five Million (5,000,000) doses.
19/07/2021 2:07 PM
wayneforwin Heard that some internal people mentioning that KANGER previously build connection in Sabah and Sarawak and now they will working together with DUOPHARMA to distribute sinopharm to supply for Malaysia
19/07/2021 2:40 PM
Lifeunlimited https://www.klsescreener.com/v2/news/view/856153
19/07/2021 2:48 PM
Lifeunlimited https://www.nst.com.my/business/2021/07/709633/bursa-spotlight-duopharma-kanger-following-sinopharm-covid-19-vaccine
19/07/2021 2:59 PM
pearlcapital Kanger enters deal to buy five million doses of Sinopharm Covid-19 vaccines

https://www.theedgemarkets.com/article/kanger-enters-deal-buy-five-million-doses-sinopharm-covid19-vaccines
19/07/2021 3:25 PM
Kicimeow Ok tidur terus
19/07/2021 3:51 PM
mo1malaysia This counter like erectile dysfunction. Give viagra also cannot naik.
19/07/2021 4:07 PM
Valgrovest Patience lah...when it wake up it will fly up all the way !
19/07/2021 4:47 PM
Trevor777 Is Dparma being used as "second fiddle" again after playing the Sputnik V prop up man? Sputnik V had been dragged for miles and NPRA approval depends on WHO, whom are..hhmmm..

Dpharma, is said to be Registered Holder of Sinopharm, but Kanger has placed an order for 5 million doses ahead of Dpharma? Sinopharm is imported prepacked, and no FnF is necessary?

Secondly, Sinopharm is to be distributed to Private sectors and not used in NIP as with Pfizer and AZ?

Anyone with better understanding, please share..
21/07/2021 8:05 AM
Bgt 9963 Good morning.!
21/07/2021 8:37 AM
Newbie1198 Will it bounce back?
21/07/2021 4:28 PM
mo1malaysia Wont, give viagra also wont bounce back.. Mati pucuk punya counter. Disappointing...
21/07/2021 4:35 PM
Ron90 sure got govt contract, at leasi 2 million jabs.
21/07/2021 4:48 PM
Newbie1198 https://www.theedgemarkets.com/article/sinopharms-covid19-shot-induces-weaker-antibody-responses-delta-variant-%E2%80%94-study
21/07/2021 5:25 PM
rr1688 THAI stop exporting AZ...SINOPHARM the largest biotech in CHINA can take over...
21/07/2021 10:46 PM
gohkimhock Chile becomes the 69th country to register Sputnik V vaccine
22/07/2021 1:42 AM
mo1malaysia Mati la this counter. Really menyusahkan people...
22/07/2021 9:54 AM
startrader Back to gkove counters
22/07/2021 10:38 AM
Ron90 useless company, vaccine got approval pun cannot make money.. look at pharma, can produce 14 million doses faster supply 4 months in advance and also can sell to other countries.
22/07/2021 12:20 PM
juju Taking time to spike that will be stable
23/07/2021 7:50 AM
Bgt 9963 Good morning.!
23/07/2021 8:56 AM
433tikitaka all cb director should resign. very malas. tidur 24 hours
23/07/2021 4:49 PM
433tikitaka since before i knew this company run by malas people
23/07/2021 4:50 PM
433tikitaka so cannot go anywhere
23/07/2021 4:50 PM
433tikitaka luckily i cabut earlier at. invest in gloves and a bit in pharmaniaga
23/07/2021 4:51 PM
23/07/2021 4:51 PM
kermit21 https://www.orientaldaily.com.my/news/nation/2021/07/24/426400?fbclid=IwAR3OKhM44QTjk4R5qExXHvEQ8sCGhUpYUBZnOTVffR8EiwHcg1VBELH8dm0
24/07/2021 10:02 PM
rr1688 according to latest health expert report...booster shots are required every 6 months...biotech is worth usd750 billion...will be worth usd 1 TRILLION or more...astronomical...
25/07/2021 8:15 PM
rr1688 SPUTNIK V is expected to receive world of good news in the near future...awesome...
25/07/2021 8:38 PM